Last updated: 2026-09-06 17:14:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Rapid Micro Biosystems, Inc. (RPID) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $1,30, with a market capitalisation of $69,72M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,30 to $4,94. This page covers its latest market performance, valuation, price trends and company information.
$69,72M | |
$1,41 | |
$27,04 | |
$0,58 | |
$1,38 | |
369,00K | |
-- | |
-- | |
$4,94 | |
$1,30 | |
-- | |
-- |
Rapid Micro Biosystems, Inc. (RPID) last closed at $1,38 as of 2026-09-04 22:07:00, unchanged from the previous close of $1,38.
During the latest regular trading session, RPID traded between $0,58 and $27,04, with a volume of 369,00K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Rapid Micro Biosystems, Inc. (RPID) moved from $1,60 to $1,30, representing a decline of 18,88% ($0,30).
The stock traded between $1,30 and $1,45 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 180,28 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0,1%
RPID is currently trading at $1,30, placing it 0,1% of the way from its 52-week low of $1,30 to its 52-week high of $4,94. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 171 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Rapid Micro Biosystems, Inc. (RPID) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.